Our comprehensive analysis, using bioinformatics tools and experimental validations, revealed distinct expression profiles of RBP family members across various cancers, highlighting the critical role of RBP4 and RBP7 in the context of triple-negative breast cancer biology. Here, RBP4 is linked to triple-negative breast carcinoma.